NZ183157A - Disodium cromoglycate containing less than 5 percent of water compositions - Google Patents

Disodium cromoglycate containing less than 5 percent of water compositions

Info

Publication number
NZ183157A
NZ183157A NZ183157A NZ18315777A NZ183157A NZ 183157 A NZ183157 A NZ 183157A NZ 183157 A NZ183157 A NZ 183157A NZ 18315777 A NZ18315777 A NZ 18315777A NZ 183157 A NZ183157 A NZ 183157A
Authority
NZ
New Zealand
Prior art keywords
percent
containing less
water compositions
disodium cromoglycate
cromoglycate containing
Prior art date
Application number
NZ183157A
Other languages
English (en)
Inventor
C Booles
K Brown
Wf Kirk
Na Stevenson
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26238506&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ183157(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB3672/76A external-priority patent/GB1562901A/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of NZ183157A publication Critical patent/NZ183157A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ183157A 1976-01-30 1977-01-25 Disodium cromoglycate containing less than 5 percent of water compositions NZ183157A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3672/76A GB1562901A (en) 1976-01-30 1976-01-30 Disodium cromoglycate
GB5113676 1976-12-08

Publications (1)

Publication Number Publication Date
NZ183157A true NZ183157A (en) 1979-08-31

Family

ID=26238506

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ183157A NZ183157A (en) 1976-01-30 1977-01-25 Disodium cromoglycate containing less than 5 percent of water compositions

Country Status (14)

Country Link
JP (1) JPS5294411A (es)
AU (1) AU512593B2 (es)
DE (1) DE2703119A1 (es)
DK (2) DK154766C (es)
ES (1) ES455478A1 (es)
FI (1) FI770215A (es)
FR (1) FR2339604A1 (es)
IE (1) IE44760B1 (es)
IL (1) IL51314A (es)
LU (1) LU76661A1 (es)
NL (1) NL185446C (es)
NO (2) NO151860C (es)
NZ (1) NZ183157A (es)
SE (2) SE442268B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU522792B2 (en) * 1977-07-19 1982-06-24 Fisons Plc Pressure pack formulation
GB2077100B (en) * 1980-04-30 1985-04-24 Fisons Ltd Pharmaceutical compositions containing cromoglycates
ZA812811B (en) * 1980-04-30 1982-06-30 Fisons Ltd Mixtures and salts of beta-2 selective bronchodilators with cromoglycic acid and salts thereof
JPS63138228U (es) * 1987-03-05 1988-09-12
JPS63138229U (es) * 1987-03-05 1988-09-12
GB8819490D0 (en) * 1988-08-16 1988-09-21 Fisons Plc Pharmaceutical devices
DE68915203T2 (de) * 1988-03-22 1994-09-22 Fisons Plc, Ipswich, Suffolk Pharmazeutische Mischungen.
GB8829478D0 (en) * 1988-12-16 1989-02-01 Harris Pharma Ltd Formulations
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
AU663906B2 (en) * 1991-12-12 1995-10-26 Glaxo Group Limited Medicaments
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
ATE171865T1 (de) * 1991-12-12 1998-10-15 Glaxo Group Ltd Arzneimittel
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
DE69218455T2 (de) 1991-12-18 1997-10-23 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzusammensetzungen für arzneimittelsuspensionen
WO2000006121A1 (de) 1998-07-24 2000-02-10 Jago Research Ag Medizinische aerosolformulierungen
WO2000007567A1 (de) 1998-08-04 2000-02-17 Jago Research Ag Medizinische aerosolformulierungen
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
ES2691033T3 (es) 2007-02-11 2018-11-23 Map Pharmaceuticals Inc. Método de administración terapéutica de DHE para activar el alivio rápido de la migraña a la vez que se reduce al mínimo el perfil de los efectos secundarios

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (es) * 1956-03-21 1900-01-01
BE556587A (es) * 1957-01-31 1957-04-11
GB1063512A (en) * 1962-11-30 1967-03-30 Benger Lab Ltd Aerosols
US3282791A (en) * 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
IL44022A0 (en) * 1973-01-23 1974-05-16 Fisons Ltd Novel salts of anti-inflammatory quinoline derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DE2703119C2 (es) 1990-10-25
JPS5294411A (en) 1977-08-09
NO151860B (no) 1985-03-11
SE442268B (sv) 1985-12-16
DK357588D0 (da) 1988-06-29
DK38077A (da) 1977-07-31
IL51314A0 (en) 1977-03-31
NO780183L (no) 1977-08-02
LU76661A1 (es) 1977-08-03
IE44760L (en) 1977-07-30
FR2339604B1 (es) 1980-12-05
DK156876B (da) 1989-10-16
DK357588A (da) 1988-06-29
SE7700888L (sv) 1977-07-31
FR2339604A1 (fr) 1977-08-26
SE8107278L (sv) 1981-12-04
DK154766B (da) 1988-12-19
JPS6129929B2 (es) 1986-07-10
IE44760B1 (en) 1982-03-24
DK154766C (da) 1989-05-22
NL185446B (nl) 1989-11-16
SE442267B (sv) 1985-12-16
FI770215A (es) 1977-07-31
AU2162677A (en) 1978-08-03
NO770286L (no) 1977-08-02
NL7700911A (nl) 1977-08-02
NL185446C (nl) 1990-04-17
NO151860C (no) 1985-06-19
DK156876C (da) 1990-03-12
DE2703119A1 (de) 1977-08-04
AU512593B2 (en) 1980-10-16
ES455478A1 (es) 1978-02-01
IL51314A (en) 1980-03-31

Similar Documents

Publication Publication Date Title
NZ183157A (en) Disodium cromoglycate containing less than 5 percent of water compositions
GB2020550B (en) Compositions containing acyl carnitines
JPS5569598A (en) Manufacture of 4*66dii00*aminoglycosyl**1*33 diaminocyclitols
JPS52153964A (en) Preparation of benzimidazolonee*2*
PT66161A (en) Novel composition of matter
JPS54122287A (en) Manufacture of 33hydroxyy66phenyll1*2*3*44 tetrahydroo1*55benzodiazosin
JPS54163532A (en) Manufacture of 2*66dialkyllnnalkylaniline
JPS5555161A (en) Intermediate for manufacture of 1*55disubstitutedd22pyrrolidones
JPS54148716A (en) Manufacture of 33hydroxyy2*2*44trimethyll pentylisobutyrate
JPS5519274A (en) Manufacture of 1*77octadiene
JPS5323974A (en) Preparation of 55aminoo1*2*33thiadiazole
JPS5519275A (en) Manufacture of 1*77octadiene
JPS52139155A (en) Compositions of high molecular compounds stabilized
JPS5346974A (en) Preparation of thiazolinee*3*
JPS54154703A (en) Manufacture of 1*22dichloroethane
JPS5553226A (en) Manufacture of 2*33dimethyll2*33butanediol
JPS54157585A (en) Manufacture of 1*44benzodiazepin
JPS54130505A (en) Manufacture of 1*77octadiene
JPS54132507A (en) Manufacture of 1*77octadiene
JPS5293777A (en) Preparation of 1*22benzothiadinee33carboxyamide
JPS54122244A (en) Manufacture of 1*22dioxime
JPS52116485A (en) Preparation of 33phenylpyridazonee*6*
JPS5545683A (en) Manufacture of 1*2*33thiadiazolee55yllurea
JPS54106482A (en) Manufacture of 2*44difluoroollaminoosstriazine
JPS5515418A (en) Manufacture of 1*44benzodiazepinn22ones